Good Clinical Practice Exam | Verified Exam Questions and Answers |
Latest Updated Study Material 2026
Question:
Which of the following best describes the principle of Respect for Persons as Described in the
Belmont Report?
a) Risk/benefit assessment, justification of research, comprehension
b) comprehension, conflicts of interest, risk/benefit ration
c) information, comprehension, voluntariness
d) voluntariness, risk/benefit assessment. selection of subjects.
Answer:
C
Question:
is the degree to which, or the rate at which, a medication or other substance
is absorbed or becomes available at the targeted place in the body.
Answer:
Bioavailability
Question:
means that subjects are split into at least two groups: those receiving the
experimental agent and those receiving a standard treatment for the condition (an active control),
no treatment, or a placebo. If subjects are assigned randomly into these groups, the study is a
randomized controlled trial.
Answer:
Controlled
Question:
is a standard for the design, conduct, performance, monitoring, auditing,
recording, analyses, and reporting of clinical trials.
Answer:
Good
Clinical Practice (GCP)
,Question:
describes the effects of the agent while in the body.
Answer:
Pharmacodynamics
Question:
is the use of genetic information to predict whether a drug will help make a
patient well or ill.
Answer:
Pharmacogenomics
Question:
describes how the agent moves through and is excreted from
the body.
Answer:
Pharmacokinetics
Question:
The first step in the drug-development process allows investigators to evaluate the drug using
tissue cultures and animal models. This research is referred to as .
Answer:
preclinical studies
Question:
is a compilation of the pre-clinical and clinical data on the investigational
product(s) that are relevant to the study of the product(s) in human subjects.
Answer:
The Investigator's Brochure (IB)
Question:
ICH E6 also defines what a " " of the original record is. In order for a
record to be (this), the paper or electronic copy of the original record must have been verified
(for example, by a dated signature) or generated through a validated process to produce an exact
copy of the original.
Answer:
Certified Copy
, Question:
The first Investigator's Brochure IB for a proposed clinical trial of a new drug is based primarily
on which of the following?
a) preclinical trials
b) Phase II studies.
Answer:
preclinical trials
Question:
Development of most new drugs, from discovery to marketing approval, usually takes:
A) 5 years
B) Less than 5 months
C) 1-3 years
D) 9 years or more
Answer:
D
Question:
Adults with more than a twelve (12)-month history of migraines were assigned randomly in a
double-blinded study to receive treatment with experimental drug X (10 or 20 mg/day) or
placebo. The primary efficacy measure was the reduction in severity of the migraine attacks.
Enrollment was twelve-hundred (1200) subjects. Which of the following best describes the
clinical phase of this study?
A) Phase II
B) Phase III
C) Pre-clinical
D) Phase I
Answer:
B
Question:
Long-term toxicology of an experimental drug in animals most likely refers to which part of drug
development?
Latest Updated Study Material 2026
Question:
Which of the following best describes the principle of Respect for Persons as Described in the
Belmont Report?
a) Risk/benefit assessment, justification of research, comprehension
b) comprehension, conflicts of interest, risk/benefit ration
c) information, comprehension, voluntariness
d) voluntariness, risk/benefit assessment. selection of subjects.
Answer:
C
Question:
is the degree to which, or the rate at which, a medication or other substance
is absorbed or becomes available at the targeted place in the body.
Answer:
Bioavailability
Question:
means that subjects are split into at least two groups: those receiving the
experimental agent and those receiving a standard treatment for the condition (an active control),
no treatment, or a placebo. If subjects are assigned randomly into these groups, the study is a
randomized controlled trial.
Answer:
Controlled
Question:
is a standard for the design, conduct, performance, monitoring, auditing,
recording, analyses, and reporting of clinical trials.
Answer:
Good
Clinical Practice (GCP)
,Question:
describes the effects of the agent while in the body.
Answer:
Pharmacodynamics
Question:
is the use of genetic information to predict whether a drug will help make a
patient well or ill.
Answer:
Pharmacogenomics
Question:
describes how the agent moves through and is excreted from
the body.
Answer:
Pharmacokinetics
Question:
The first step in the drug-development process allows investigators to evaluate the drug using
tissue cultures and animal models. This research is referred to as .
Answer:
preclinical studies
Question:
is a compilation of the pre-clinical and clinical data on the investigational
product(s) that are relevant to the study of the product(s) in human subjects.
Answer:
The Investigator's Brochure (IB)
Question:
ICH E6 also defines what a " " of the original record is. In order for a
record to be (this), the paper or electronic copy of the original record must have been verified
(for example, by a dated signature) or generated through a validated process to produce an exact
copy of the original.
Answer:
Certified Copy
, Question:
The first Investigator's Brochure IB for a proposed clinical trial of a new drug is based primarily
on which of the following?
a) preclinical trials
b) Phase II studies.
Answer:
preclinical trials
Question:
Development of most new drugs, from discovery to marketing approval, usually takes:
A) 5 years
B) Less than 5 months
C) 1-3 years
D) 9 years or more
Answer:
D
Question:
Adults with more than a twelve (12)-month history of migraines were assigned randomly in a
double-blinded study to receive treatment with experimental drug X (10 or 20 mg/day) or
placebo. The primary efficacy measure was the reduction in severity of the migraine attacks.
Enrollment was twelve-hundred (1200) subjects. Which of the following best describes the
clinical phase of this study?
A) Phase II
B) Phase III
C) Pre-clinical
D) Phase I
Answer:
B
Question:
Long-term toxicology of an experimental drug in animals most likely refers to which part of drug
development?
